
<DOC>
<DOCNO>WT03-B24-169</DOCNO>
<DOCOLDNO>IA064-000378-B002-180</DOCOLDNO>
<DOCHDR>
http://www.sosei.com:80/Companies/genpharm.html 206.86.52.80 19970112095213 text/html 3683
HTTP/1.0 200 OK
Date: Sun, 12 Jan 1997 09:52:10 GMT
Server: BESTWWWD/1.0
MIME-version: 1.0
Content-type: text/html
Content-length: 3501
Last-modified: Sun, 17 Nov 1996 18:21:20 GMT
</DOCHDR>
<HTML> 
<HEAD><TITLE>GenPharm International</TITLE></HEAD> 
<BODY BGCOLOR="#FFFFFF">
<IMG BORDER= 0 SRC="../Graphics/genpharm.gif">
<H2>GenPharm International, Inc.</H2>
<H3>Corporate Profile</H3>
<!--<A HREF = "ipijp.html"><IMG  Align=Middle SRC="../Graphics/japanese.gif"></A
> <A HREF = "ipijp.html">Japanese Translation</A>-->
<HR>
297 N. Bernardo Avenue<BR>
Mountain View, CA 94043<BR>
(415) 964-7024 (voice)<BR>
(415) 964-3537 (fax)<P>
<HR>
<B>Company Officers:</B><BR>
<A HREF="MAILTO:lhunter353@aol.com">Jonathan MacQuitty, CEO</A><P>
<B>Employees:</B>	13<P>
<B>Facilities:</B>	15,000 sq. ft. of laboratory office and animal facilities in the U.S.<P>

<B>Principal Investors:</B><P>


<CENTER><TABLE BORDER=5>
<TR><TD>Abingworth Management</TD><TD>Institutional Venture Partners</TD></TR>
<TR><TD>Atlas Ventures</TD><TD>Kleiner, Perkins, Caufield & Byers</TD></TR>
<TR><TD>Charterhouse Venture</TD><TD>Kokusai Finance Co., Ltd.</TD></TR>
<TR><TD>Collagen Corp.</TD><TD>Merrill, Pickard, Anderson & Eyre</TD></TR>
<TR><TD>Daiwa</TD><TD>New Enterprise Associates</TD></TR>
<TR><TD>Delphi Ventures</TD><TD>Newtek Ventures</TD></TR>
<TR><TD>Eli Lilly</TD><TD>Nichimen Corp.</TD></TR>
<TR><TD>Euroventures</TD><TD>PaineWebber Development</TD></TR>
<TR><TD>Fairfield Venture Partners</TD><TD>SED Ventures</TD></TR>
<TR><TD>Fujigin Capital Co.</TD><TD>Sequoia Capital</TD></TR>
<TR><TD>Funai Capital Corp.</TD><TD>Techno-Venture Co. Ltd.</TD></TR>
<TR><TD>Genencor International</TD><TD></TD></TR>
</TABLE></CENTER><P>

<B>Corporate Overview:</B><P>

Develop and commercialize fully human monoclonal antibodies based on transgenic animal technology.<P>

<B>Research & Development:</B><P>

HuMAb-Mouse (tm) transgenic system for the production of fully human MAbs.<P>

<B>Agreements:</B><P>


<!-- Table Tag -->
<CENTER><TABLE CELLSPACING=3 CELLPADDING=3 BORDER=3>
<TR><TH>Name</TH><TH>Products</TH><TH>Content of Agreement</TH><TH>Date</TH></TR>
<TR><TD>Baylor Univ.</TD><TD>murine embryonic stem cells</TD><TD>license to technology developed by Dr. Allan Bradley</TD><TD>1990</TD></TR>
<TR><TD>DNX</TD><TD>microinjection technology</TD><TD>cross-licensing agreement with right to sublicense transgenic animal products</TD><TD>1991</TD></TR>
<TR><TD>Eisai Co Ltd.</TD><TD>human MAbs for one unnamed antigen</TD><TD>exclusive rights for Asia or one antigen</TD><TD>1993</TD></TR>
<TR><TD>Genencor Int.</TD><TD>molecular biology and other technology for transgenic applications</TD><TD>exclusive R&D agreement</TD><TD>1988</TD></TR>
<TR><TD>Medical Research Council</TD><TD>dominant activating sequences</TD><TD>license to technology developed by Dr. Frank Grosveld</TD><TD>1991</TD></TR>
<TR><TD>Univ. of Utah</TD><TD>homologous recombination techniques for gene targeting and MAb production</TD><TD>exclusive rights to technology developed by  Dr. Mario Capecchi</TD><TD>1990</TD></TR>
</TABLE></CENTER>
<P>
<A HREF="http://www.sosei.com/"><IMG ALIGN=MIDDLE SRC="../Graphics/home_button.gif"><A HREF="http://www.sosei.com/">&nbsp;Home Page</A><P>
<HR>
</BODY>

<ADDRESS><FONT SIZE=3>Updated December 18, 1995.<BR>
Copyright &copy: 1996 <A HREF="http://www.genweb.com/">GenWeb</A>. All rights reserved.</FONT></ADDRESS>

<!-- Contact Person:
Date:		12/18/95
Name:	Leslie Flint
Title:		Director Administration
Address:	GenPharm International, Inc.
		297 N. Bernardo Avenue
City		Mountain View
State:		CA
Zip:		94043
Telephone:	(415) 964-7024
Fax:		(415) 964-3537
e-mail:	lflint@genpharm.com-->
</HTML>
</DOC>